£70.83

About as cheap as it gets — within 5% of the all-time low it hit 3 months ago.

£71 today · all-time low £70 (Jul 2026) · usually £71

Springer Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies: 183 (Cancer Treatment and Research, 183)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 61 days · 61 data points (no recent data)

Historical
Generating forecast…
£70.97 £70.27 £70.42 £70.57 £70.73 £70.88 £71.03 26 July 2026 10 August 2026 25 August 2026 09 September 2026 24 September 2026
View at Amazon ↗

Price data last checked 30 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 61 days • 2 price levels

Days at Price
Current Price
47 days · current 14 days · current 0 12 24 35 47 £70 £71 Days at Price

Price Analysis

Most common price: £70 (47 days, 77.0%)

Price range: £70 - £71

Price levels: 2 different prices over 61 days

Description

This book presents the clinical scope of cancer immunotherapeutic agents for solid tumors and Hematologic malignancies, elaborates on the scientific details of their modes of action, and presents the impact of these agents on oncology, patients and the broader healthcare system. At present, cancer immunotherapies fall broadly into three categories: immune checkpoint inhibitors (ICIs), adoptive T cell therapies, and cancer vaccines which have distinct mechanisms of action. Immune checkpoint inhibitors rely upon disrupting tumor antigen recognition as self by the immune system through inhibition of checkpoint molecules. Adoptive T cell therapies involve the engineering of T cells ex vivo to target and destroy tumor cells. The first part of this book will provide an overview of the discovery and mechanistic details of the technology. The second part will be devoted to elaborating on the clinical outcomes, successes and limitations for specific tumor subtypes, which includes bothsolid tumors and hematologic malignances for both pediatric and adult populations. As such, the book offers a valuable resource for oncologists, hematologists, and all those seeking an up-to-date overview of cancer immunotherapies.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
13 May 2023
Listed Since
17 April 2023

Barcode

No barcode data available

Similar Products You Might Like

Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies: 183 (Cancer Treatment and Research, 183)
100% match

Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies: 183 (Cancer Treatment and Research, 183)

Springer

£95.74 03 Oct 2026
Academic Press Cell-based Cancer Immunotherapy Vol 183
98% match

Academic Press Cell-based Cancer Immunotherapy Vol 183

Elsevier

£134.00 01 Oct 2026
Immuno-oncology and Immunotherapy Part F: Volume 201 (Methods in Cell Biology, Volume 201)
98% match

Immuno-oncology and Immunotherapy Part F: Volume 201 (Methods in Cell Biology, Volume 201)

Elsevier

£131.64 24 Sep 2026
Cancer Immunotherapy (Volume 209) (Progress in Molecular Biology and Translational Science, Volume 209)
98% match

Cancer Immunotherapy (Volume 209) (Progress in Molecular Biology and Translational Science, Volume 209)

Elsevier

£114.00 03 Oct 2026
Cancer Immunotherapy: Methods and Protocols: 2748 (Methods in Molecular Biology, 2748)
98% match

Cancer Immunotherapy: Methods and Protocols: 2748 (Methods in Molecular Biology, 2748)

Humana

£99.30 24 Sep 2026
Immuno-oncology and Immunotherapy Part A - Volume 189
98% match

Immuno-oncology and Immunotherapy Part A - Volume 189

Elsevier

£120.99 03 Oct 2026
Interaction of Immune and Cancer Cells: 113 (Experientia Supplementum, 113)
98% match

Interaction of Immune and Cancer Cells: 113 (Experientia Supplementum, 113)

Springer

£131.39 30 Sep 2026
Immuno-oncology and Immunotherapy Part D - Volume 196
98% match

Immuno-oncology and Immunotherapy Part D - Volume 196

Elsevier

£138.99 03 Oct 2026
Academic Press Immuno-oncology and Immunotherapy Vol 190
98% match

Academic Press Immuno-oncology and Immunotherapy Vol 190

Elsevier

£133.99 03 Oct 2026
Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
98% match

Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors

Springer

£110.83 23 Sep 2026
Immunothérapie des cancers au troisième millénaire
98% match

Immunothérapie des cancers au troisième millénaire

EDP SCIENCES

£76.33 18 Sep 2026
Tumor Microenvironment: 180 (Cancer Treatment and Research, 180)
98% match

Tumor Microenvironment: 180 (Cancer Treatment and Research, 180)

Springer

£78.70 30 Sep 2026
Frontiers in Cancer Immunology; Systems Biology in Cancer Immunotherapy: 2
98% match

Frontiers in Cancer Immunology; Systems Biology in Cancer Immunotherapy: 2

Bentham Science Publishers

£87.87 19 Sep 2026
Immuno-oncology and Immunotherapy Part C - Volume 191
98% match

Immuno-oncology and Immunotherapy Part C - Volume 191

Elsevier

£133.99 03 Oct 2026
Immuno-oncology and Immunotherapy Part E - Volume 199
98% match

Immuno-oncology and Immunotherapy Part E - Volume 199

Elsevier

£138.99 03 Oct 2026
Targets of Cancer Diagnosis and Treatment: Ion Transport in Tumor Biology: 183 (Reviews of Physiology, Biochemistry and Pharmacology, 183)
98% match

Targets of Cancer Diagnosis and Treatment: Ion Transport in Tumor Biology: 183 (Reviews of Physiology, Biochemistry and Pharmacology, 183)

Springer

£100.11 19 Sep 2026
Advances in Cancer Immunotherapy
98% match

Advances in Cancer Immunotherapy

IntechOpen

£119.00 03 Oct 2026
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
98% match

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers

Springer

£123.15 29 Aug 2026
Cancer Treatment: An Interdisciplinary Approach: 2 (Interdisciplinary Cancer Research, 2)
97% match

Cancer Treatment: An Interdisciplinary Approach: 2 (Interdisciplinary Cancer Research, 2)

Springer

£121.64 04 Sep 2026
Cancer Immunotherapy Principles and Practice - Medical Reference
97% match

Cancer Immunotherapy Principles and Practice - Medical Reference

£151.94 01 Mar 2026
CANCER IMMUNOTHERAPY PRINCIPLES AND PRACTICE: Advancing the Science and Practice of Immune-Based Cancer Therapies
97% match

CANCER IMMUNOTHERAPY PRINCIPLES AND PRACTICE: Advancing the Science and Practice of Immune-Based Cancer Therapies

£163.34 24 Jan 2026
Principles of Immunotherapy in Breast and Gastrointestinal Cancers: Activity, Mechanisms of Resistance and New Sensitization Strategies (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy)
97% match

Principles of Immunotherapy in Breast and Gastrointestinal Cancers: Activity, Mechanisms of Resistance and New Sensitization Strategies (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy)

Elsevier

£117.40 24 Sep 2026
Advancements in Personalized Cellular Immunotherapy: A Comprehensive Guide to Cancer Treatment
97% match

Advancements in Personalized Cellular Immunotherapy: A Comprehensive Guide to Cancer Treatment

Elsevier

£127.35 04 Sep 2026
Challenging Cases in Immunotherapy Related Organ Toxicities
97% match

Challenging Cases in Immunotherapy Related Organ Toxicities

Springer

£86.34 17 Sep 2026